Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. - Wikidata - awgldk - TriplyDB

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

http://www.wikidata.org/entity/Q34693858

about

Nitric oxide and peroxynitrite in health and disease NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential cGMP-independent nitric oxide signaling and regulation of the cell cycle.Nitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosis Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk Nanoparticulate carriers for the treatment of coronary restenosis The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation Essential role of protein kinase G and decreased cytoplasmic Ca2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling Improved adenovirus vectors for infection of cardiovascular tissues Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system.N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury.Molecular advances in cardiac and cardiovascular disease.Hemodynamically driven stent strut design The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Benzo[a]pyrene activates interleukin-6 induction and suppresses nitric oxide-induced apoptosis in rat vascular smooth muscle cells Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces the vasoconstrictive response.Endothelial nitric oxide in humans in health and disease.A pivotal role of nitric oxide in endothelial cell dysfunction.Apoptosis in the vasculature: mechanisms and functional importance.The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine.Role of nitric oxide in progression and regression of atherosclerosis Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis.Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries Local gene delivery to the vessel wall.Restenosis and gene therapy.Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.Nonviral gene transfer strategies for the vasculature.Nitrate ingestion: a review of the health and physical performance effects Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury.Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering.Gene therapy for cerebral vascular disease: update 2003.Applied gene therapy in preclinical models of vascular injury.Paradoxes of nitric oxide in the diabetic kidney.Nitric oxide increases lysine 48-linked ubiquitination following arterial injury.Translational paradigms in cerebrovascular gene transfer.Nitric oxide affects UbcH10 levels differently in type 1 and type 2 diabetic rats.

P2860

Q24645400-99A0C656-6C1E-4C18-BC0D-216DAB251720 Q24656131-55BB1DEF-F952-4563-9FFD-74E0F0491622 Q24811327-664E7E6D-8EEE-4F0D-BA5D-0A0E05F8BF3C Q28193414-2E30BFD6-9204-4948-A55D-A260FDABECCF Q28201060-4304314E-F20F-478F-BF88-CB27A818667C Q28220309-7F60FF47-9A4C-4E17-8D99-CD0FB0B48CBF Q28578896-E560162C-E9E3-4EFE-B699-8C0847DA34C6 Q28579176-483C744C-E937-4260-9E3E-FD344B85159F Q28582613-12C56F63-F160-4BBC-9E10-C4C23671E5F5 Q28592810-C914168B-0531-46FC-A5AA-7E6A8AADDFF6 Q30657410-125CDA36-EC60-4E52-9640-9760717E06FD Q30716866-96C038B3-24B6-42F8-B020-9566781DE126 Q31027190-86680400-B1F4-449C-9B11-C7079D91B691 Q33641514-A2218F5F-C938-4D55-937E-C45B07064D6B Q33644087-4BF638AD-6DFB-4092-9E69-6A5D382950B0 Q33688733-5B092379-53F1-4978-BA33-17042503BCA4 Q33713112-9FF41A7A-4714-4768-8DAD-4383888BE996 Q33807737-C3FF2795-EB00-4C6B-8604-BB6C21A5AD4F Q33815804-EFC212DA-8256-418C-9C4F-8BCCF42A13E1 Q33848393-A22433C7-6141-4BAC-B8E8-84B09FD6A314 Q33959479-50B0AEB2-B7EE-4FFF-A97C-374EF5CF3370 Q34060215-9A862746-35BB-49DF-BF71-61F7D35B648F Q34183363-BB455FC9-FFDE-4D8F-A34D-889D739B5978 Q34203043-D51E29B1-D948-489D-BAE1-CDACD5600E0E Q34405720-936E3DB6-8B4A-4C2B-93E9-4B6E2FE2BB26 Q34418987-E342ED54-618B-4666-8A16-765907C9D8B4 Q34452138-0F0E6229-6F8E-4541-BF7E-F98720269613 Q34482530-CE6CBD49-40CB-4F4E-8834-EC9B0050570A Q34502023-D266A242-5F4E-4AE1-A0DF-C5BBE049A2B1 Q34565066-15E7C12C-3AAC-4CE1-B3A2-3C6A11934719 Q34578133-05FADADC-CD8E-4366-802A-BE53051488AB Q34662166-5B993E4E-C5B7-410F-8843-53A65C61A745 Q34755179-9673EFD1-CCF6-415C-9CDB-DE435EEB0C68 Q34981655-02B507EC-BACF-43EF-9D35-5364EC64A5AF Q35045240-53A42F4F-6AC6-4DF6-989C-C7CFF623F1D1 Q35095408-1A21E33C-5290-4EE5-A52D-2A9E66E52BF1 Q35123478-C91859A6-CED3-4276-971D-007F852B5755 Q35159280-36A564E2-FEBD-4C9E-B98E-989E9DF58C9B Q35576698-88BEAABC-CE43-4E21-8201-CE83D3A5E324 Q35602473-2C337430-430A-41AB-B482-4EBCC7140F0B

P2860

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

http://www.wikidata.org/entity/Q34693858

description

1995 nî lūn-bûn

@nan

1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@ast

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@en

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@nl

type

label

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@ast

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@en

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@nl

prefLabel

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@ast

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@en

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@nl

P1433

Q34693858-A231468E-8D2E-4D0B-BDD0-6D3F397371BC

P1476

Q34693858-B9F3E77C-00A8-4905-8AA7-1663EA138A90

P2093

Q34693858-006DB704-1384-43CD-80D1-2D7587F943BB

Q34693858-04C830A2-CCEC-487B-93ED-247214A15070

Q34693858-121A4635-81A0-411B-9432-4E564C1E3B34

Q34693858-169E9712-F68C-4ED5-8138-28DA1169ACCE

Q34693858-2631B8B4-C4CE-49BF-8EFB-228615701632

Q34693858-50D046DC-C682-4B44-808D-99736B0C597E

Q34693858-A297BD40-55CE-4C7D-BD44-835A91428C2F

Q34693858-BFA7E548-6156-4398-8892-4608753A6BA7

Q34693858-CBDBEBE9-F3DE-4E7B-BA52-464C24ED4B90

P2860

Q34693858-22759387-9D0D-4C4B-AAC3-98B89DEBAB68

Q34693858-30AD9AA9-608D-4534-AC12-0560A5E99931

Q34693858-367F6695-B8AC-495C-9E28-641286DCC122

Q34693858-3EA24008-28E8-45D3-900A-BC2FE914F2C4

Q34693858-6C3911C7-10B6-49C2-B2F3-5E9F4797F449

Q34693858-78C1F693-0D6B-4B78-948D-37561506E30A

Q34693858-79FE64C2-6E64-4048-8A37-B1DAC8F7F290

Q34693858-8841E1EC-47DE-41DF-9AF5-368837487F19

Q34693858-9DF5764F-BF09-430B-924D-32DC8D4CB4A9

Q34693858-A257F7E5-9AEF-4283-A6D4-AB1A8170AC3D

P304

Q34693858-420E3C33-B2B3-49A8-8591-C3D512DDFE79

P31

Q34693858-D1AF92F1-A9CF-4971-993A-3A56FD9FB4D4

P356

Q34693858-D6FF5019-968C-4CCB-87EF-2EBAA3DCAFAA

P407

Q34693858-5B682962-A287-470D-AC70-487D7EFF586B

P433

Q34693858-AF034ED9-44ED-4C32-B78B-134B71A8E431

P478

Q34693858-6CE39984-D596-448F-9385-133FC294FB20

P577

Q34693858-961A2F8E-4AF1-4475-843E-99AE98A385BC

P5875

Q34693858-2F16D44A-16AC-4973-88A2-B41B6409081B

P698

Q34693858-23C803B3-6CEC-4E47-8909-D605A1EFD9C7

P921

Q34693858-A41EADC9-EEC9-4BAB-ADE6-ECB6B1E304C2

Q34693858-A634202F-6997-45E0-B7FE-206ADEDD5856

P932

Q34693858-5A0FF023-A153-45F4-BAEA-D124F567ADEE

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Gene therapy inhibiting neoint ...... ll nitric oxide synthase gene.

@en

P2093

G H Gibbons

http://www.w3.org/2001/XMLSchema#string

H E von der Leyen

http://www.w3.org/2001/XMLSchema#string

J P Cooke

http://www.w3.org/2001/XMLSchema#string

L Zhang

http://www.w3.org/2001/XMLSchema#string

M Nakajima

http://www.w3.org/2001/XMLSchema#string

N P Lewis

http://www.w3.org/2001/XMLSchema#string

R Morishita

http://www.w3.org/2001/XMLSchema#string

V J Dzau

http://www.w3.org/2001/XMLSchema#string

Y Kaneda

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient selection for high-expression transfectants with a novel eukaryotic vector

The pathogenesis of atherosclerosis: a perspective for the 1990s

Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform.

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.

Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries.

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues.

P304

1137-1141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.4.1137

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15667417

http://www.w3.org/2001/XMLSchema#string

P698

7532305

http://www.w3.org/2001/XMLSchema#string

P921

P932

42653

http://www.w3.org/2001/XMLSchema#string